Clear-cell renal cell carcinoma is highly infiltrated with T cells, and therapeutic interventions such as the use of MTOR inhibitors and checkpoint inhibitors (PD-1 and PD-L1) have been shown to be effective in the management of ccRCC [52]. Here, CD274 is linked to nonpapillary renal cell carcinoma.